FP

DRUG6 trials

Sponsors

GlaxoSmithKline, Hoffmann-La Roche, United States Army Research Institute of Environmental Medicine, Teva Branded Pharmaceutical Products R&D, Inc.

Conditions

Acute Mountain SicknessAsthmaGastrointestinal InjuryRhinitis

Phase 2

A Study to Evaluate the Effect of GW870086X on Allergen Challenge in Mild Asthmatics

CompletedNCT00857857

GlaxoSmithKlineAsthma

Start: 2009-02-16End: 2009-11-03Updated: 2018-02-20

Intranasal SB-705498 in Allergic Rhinitis (AR) Patients

CompletedNCT01424397

GlaxoSmithKlineRhinitis

Start: 2011-04-14End: 2011-07-07Updated: 2019-09-13

Phase 3

A Randomized, Double-Blind, Placebo-Controlled Trial on Efficacy and Safety of Fluticasone Propionate/Albuterol Sulfate Combination in Participants 12 Years and Older With Asthma

RecruitingNCT06664619

Teva Branded Pharmaceutical Products R&D, Inc.Asthma

Start: 2024-12-12End: 2026-05-31Target: 724Updated: 2026-04-02

Phase 4

Study Of Fluticasone Propionate/Salmeterol In Asthmatic Subjects

CompletedNCT00517634

GlaxoSmithKlineAsthma

Start: 2007-08-31End: 2008-07-31Updated: 2016-12-16

Longitudinal Cohort Study in Participants With Severe Asthma to Assess Biomarkers

CompletedNCT02537691

Hoffmann-La RocheAsthma

Start: 2015-08-28End: 2017-07-10Updated: 2019-04-09

Unknown Phase

Gut-microbiota Targeted Nutritional Intervention for Gut Barrier Integrity at High Altitude

CompletedNCT04111263

United States Army Research Institute of Environmental MedicineAcute Mountain Sickness, Gastrointestinal Injury

Start: 2019-10-06End: 2022-11-05Updated: 2022-12-23

Related Papers

Assessing biomarkers in a real-world severe asthma study (ARIETTA).

2016-04-1415 citations